title: Peripheral neuropathy during infliximab therapy for rheumatoid arthritis.
authors.affiliation: Centre national de pharmacovigilance, 9, avenue Dr Zouheir Essafi, 1006 Tunis, Tunisia.
authors.forename: Sihem
authors.initials: S
authors.lastname: El Aidli
authors.affiliation: Centre national de pharmacovigilance, 9, avenue Dr Zouheir Essafi, 1006 Tunis, Tunisia. Electronic address: gaiesemna@yahoo.fr.
authors.forename: Emna
authors.initials: E
authors.lastname: Gaïes
authors.affiliation: Centre national de pharmacovigilance, 9, avenue Dr Zouheir Essafi, 1006 Tunis, Tunisia.
authors.forename: Fainene
authors.initials: F
authors.lastname: Cherif
authors.affiliation: Centre national de pharmacovigilance, 9, avenue Dr Zouheir Essafi, 1006 Tunis, Tunisia.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Zaiem
authors.affiliation: Centre national de pharmacovigilance, 9, avenue Dr Zouheir Essafi, 1006 Tunis, Tunisia.
authors.forename: Riadh
authors.initials: R
authors.lastname: Daghfous
authors.affiliation: Centre national de pharmacovigilance, 9, avenue Dr Zouheir Essafi, 1006 Tunis, Tunisia.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Lakhal
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced*; D011115:Polyneuropathies / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab